Provided by Tiger Fintech (Singapore) Pte. Ltd.

IDEAYA Biosciences

24.75
+0.42001.73%
Post-market: 24.750.00000.00%17:54 EDT
Volume:1.09M
Turnover:27.06M
Market Cap:2.17B
PE:-6.54
High:25.11
Open:24.35
Low:24.18
Close:24.33
52wk High:40.74
52wk Low:13.45
Shares:87.64M
Float Shares:82.44M
Volume Ratio:1.26
T/O Rate:1.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7869
EPS(LYR):-3.3605
ROE:-35.09%
ROA:-23.84%
PB:2.26
PE(LYR):-7.37

Loading ...

IDEAYA Biosciences’ Promising Potential with IDE849: Analyst Charles Zhu’s Buy Rating Ahead of WCLC 2025

TIPRANKS
·
Jul 28

IDEAYA Biosciences Announces New Phase 3 Clinical Trial for Neoadjuvant Darovasertib in Uveal Melanoma

Reuters
·
Jul 24

IDEAYA Biosciences Announces Proffered Paper Oral Presentation at Esmo 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma

THOMSON REUTERS
·
Jul 24

Ideaya Biosciences, Hengrui announce oral presentation at IASLC 2025

TIPRANKS
·
Jul 23

IDEAYA Biosciences Announces Phase 1 Trial Data Presentation for IDE849 in Small-Cell Lung Cancer at 2025 World Conference on Lung Cancer

Reuters
·
Jul 23

TD Cowen Initiates Coverage on IDEAYA Biosciences With Buy Rating

MT Newswires Live
·
Jul 22

Promising Pipeline and Strategic Focus Drive Buy Rating for IDEAYA Biosciences

TIPRANKS
·
Jul 22

IDEAYA Biosciences Inc. to Participate in BTIG Virtual Biotechnology Conference Fireside Chat

Reuters
·
Jul 21

IDEAYA Biosciences (IDYA) Receives a Hold from Goldman Sachs

TIPRANKS
·
Jul 10

IDEAYA Biosciences Is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 09

RBC Cuts Price Target on IDEAYA Biosciences to $30 From $57, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Jul 09

IDEAYA Biosciences Inc. Appoints Joshua Bleharski as New Chief Financial Officer

Reuters
·
Jun 28

BRIEF-Ideaya Biosciences Announces Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Jun 27

IDEAYA Biosciences Introduces New Inducement Stock Option Plan for Newly Hired Employees

Reuters
·
Jun 27

Wells Fargo Initiates Coverage on IDEAYA Biosciences With Overweight Rating, $44 Price Target

MT Newswires Live
·
Jun 26

IDEAYA Biosciences Holds Annual Stockholders Meeting

TIPRANKS
·
Jun 25

IDEAYA Biosciences Inc. Concluded Annual Stockholders Meeting

Reuters
·
Jun 25

Optimistic Buy Rating for IDEAYA Biosciences: Expanding Market Potential and Promising Clinical Data

TIPRANKS
·
Jun 04

IDEAYA Biosciences Inc. to Participate in Jefferies Global Healthcare Conference 2025

Reuters
·
Jun 02

IDEAYA Biosciences Announces New Inducement Stock Option Plan for Newly Hired Employees

Reuters
·
May 30